You may have seen the exciting news all over the press today about T Cell immunotherapy (harnessing the immune system to attack cancer) showing phenomenal results in terminal patients with certain blood cancers. In one study, 94% of participants with acute lymphoblastic leukaemia (ALL) saw symptoms vanish completely. Patients with other blood cancers had response rates greater than 80%, and more than half experienced complete remission.
Dr Alan Worsley, from Cancer Research UK, spoke to the BBC yesterday morning and said that these are very exciting results but it’s still early days and safety is paramount.
Read more here and watch Dr Worsley’s interview on the BBC.